Merck Launches Thyro Africa in Kenya
The Kenya Diabetes Study Group, Merck Pharmaceuticals, and Thyroid Africa have partnered to launch a nationwide campaign aimed at raising awareness about thyroid diseases and providing free screening services across all counties in Kenya. The Partnership pillar aims to collaborate with local labs, organizations, and policymakers to expand TSH testing and access to care.Built on three foundational pillars—Patient Awareness, Healthcare Provider (HCP) Diagnosis Excellence, and Partnership ThyroAfrica seeks to transform how thyroid disorders are understood and managed in Africa.
In a bid to address the ever growing thyroid issues in Africa, Merck- a global pharmaceutical has launched ThyroAfrica, a continent-wide thyroid awareness initiative. Players in the health sector have been urged to amplify the awareness campaign about Thyroid disease in an effort to educate the public about the prevalence and risks associated with thyroid disorders, which often go undiagnosed due to their subtle symptoms.
Speaking at the official launch Mr. John Ndeti, General Manager, Merck said that the initiative is in line with the continent’s NCD agenda as thyroid disorders affect over 12 million people in Africa many of whom remain undiagnosed.
The Partnership pillar aims to collaborate with local labs, organizations, and policymakers to expand TSH testing and access to care.
Comments
Post a Comment